Ashish Kamat interviews Francesco Del Giudice about the CUT-less trial, which aims to streamline the treatment pathway for non-muscle invasive bladder cancer. Sam Chang speaks with Vignesh Packiam ...

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being over age 55. And the unfortunate reality is that women are often diagnosed at ...